Michael Soumas

Experience: Capital Markets: Ongoing representation of several Nasdaq and NYSE public companies.; Represented an Israeli video optimization technology and solutions in their initial public offering (IPO) on the Nasdaq and follow-on public offering.; Represented an Israel company that is a global leader in vision and light control technologies in their IPO on the Nasdaq.; Represented an Israeli regenerative medicine company in their IPO on the New York Stock Exchange.; Represented an Israeli company that is a leading innovator in alternative proteins and 3D printing technologies in multiple transactions, including a follow-on public offering of American Depositary Shares and warrants, warrant inducement transaction, private investment in public equity (PIPE), equity line facility, at-the-market sale (ATM) facility.; Represented an Israeli-based company which develops systems for the prevention of strokes in multiple transactions, including PIPEs and ATM facility.; Represented an Israeli technology company that seeks to revolutionize railway safety and the data-related market in multiple transactions, including a PIPE, equity line facility, ATM facility and convertible loan facility.; Represented an Israeli technology company that develops and commercializes advanced transportation safety solutions in establishing an equity line facility.; Represented an Israeli aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry in multiple transactions, including IPO on the Nasdaq, a PIPE and registered direct offerings.; Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology and overstock management solutions in multiple transactions, including a warrant inducement transaction, ATM facility and registered direct offering.; Represented an Israeli company that is a global leader in connected home ultrasound technology in the dual listing of its ordinary shares on the Nasdaq.; Represented an Israeli-based advanced technology company in multiple transactions, including the uplisting of its common stock to the Nasdaq, PIPEs and convertible loan facility.; Represented an Israeli-based biotech company in multiple transactions, including the uplisting of its common shares to Nasdaq, registered direct offerings and convertible loan facility.; Represented an Israeli biotechnology company in multiple transactions, including their IPO on the Nasdaq and PIPE.; Represented an Israeli-based company that is a provider of cybersecurity and robust solutions for drones and robotics in multiple transactions, including its registered direct offering and ATM facility.; Represented an Israeli-based company that is a leader in AI-powered visual sensing technologies in the uplisting of its common stock to the Nasdaq.; Represented an Israel late-clinical stage biotechnology company in multiple transactions, including registered direct offering, PIPE, ATM facility and equity line facility.; Represented an Israeli clinical-stage biopharmaceutical company in multiple transactions, including follow-on public offering, equity line facility, ATM facility and establishment of a digital asset management strategy.; Represented an Israeli biotechnology company that is listed on the New York Stock Exchange on multiple transactions, including registered direct offerings, follow-on public offering, warrant inducement transactions and ATM facility.; Represented an Israeli-based clinical stage biotechnology company in multiple transactions, including follow-on public offerings, warrant inducement transactions and ATM facility.; Represented purchasers in connection with equity line programs.; Represented investment banks in connection with underwritten public offerings, PIPEs and ATM programs.; Corporate and M & A; Represented an Israeli-based advanced technologies company in its strategic acquisition in a share exchange transaction of up to 100% of the share capital of an Israeli company that is engaged in developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum-based GPS replacement and quantum atom accuracy solutions.; Represented an Israeli-based technology company in its strategic acquisition in a share exchange transaction of approximately 30% of the share capital of an Israeli company that designed and manufactures micro-mobility solutions, supporting its continued growth and market-expansion strategy.; Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology and overstock management solutions in its strategic acquisition in a share exchange transaction of 100% of the share capital of a Spanish technology company that is engaged in delivering size and fit solutions for every stage of the fashion industry's value chain.; Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology and overstock management solutions in its strategic acquisition in a share exchange transaction of 100% of the share capital of a European SaaS company specializing in AI-powered footwear sizing and fit solutions.; Represented an Israeli-based advanced technologies company in its strategic acquisition in a share exchange transaction of up to 100% of the share capital of an Israeli company that specializes in developing advanced writing assistance tools that leverage artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) technologies.; Represented an Israeli technology company that seeks to revolutionize railway safety and the data-related market in its strategic acquisition in a share exchange transaction of 51% of the share capital of an Israeli a cutting-edge quantum computing and AI company.; In-House Experience: Vice President and Counsel, Credit Suisse Securities (USA) LLC, 2014-2022